Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis.
about
Mechanisms of drug resistance: daptomycin resistanceVancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal managementβ-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.Emergence of a daptomycin-non-susceptible Enterococcus faecium strain that encodes mutations in DNA repair genes after high-dose daptomycin therapy.Bacterial Cytological Profiling (BCP) as a Rapid and Accurate Antimicrobial Susceptibility Testing Method for Staphylococcus aureus.Emergence of High-Level Daptomycin Resistance in Corynebacterium striatum in Two Patients with Left Ventricular Assist Device Infections.Daptomycin in Combination with Ceftolozane-Tazobactam or Cefazolin against Daptomycin-Susceptible and -Nonsusceptible Staphylococcus aureus in an In Vitro, Hollow-Fiber Model.Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model.Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-resistant Enterococcus faecium Isolates in an In Vitro PK/PD Model of Infection.Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes.New Guidelines Endorse Old Recommendations for Invasive Enterococcal Infections.
P2860
Q26779944-8133FA8D-0418-4447-B32B-89BC8193419FQ26798630-7CB46F8C-3B96-496E-879C-525B6AC4DAAAQ35385108-9CB3C3FF-C20B-4744-8401-65E7860FD6C1Q35746209-A1ECF8D9-DB23-42CF-9DC6-A3923BEEED56Q35977134-65976278-E936-46E5-9F75-D0D5A4AC62E3Q36645037-6B32F944-B132-4E83-A1F6-536ACFF40AF6Q36806332-08C4EC4B-1B46-416D-9867-5A0077211CD3Q37023118-42D9A99D-BC86-4EA3-BF24-06D297A7D509Q37287661-55E9E72F-0B21-4538-8AE0-636CC0FF01E8Q39168565-5300902F-5C5E-423E-B4D0-C38A4D2575DEQ40103272-DC2028F9-0C21-4151-97DC-D1060BBDFD7CQ40254524-D9419975-1859-49EC-B6F0-FB36B319D6EDQ43430678-85F053F2-7D5B-4037-8656-132AA8DEC486
P2860
Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Defining daptomycin resistance ...... occus faecium and E. faecalis.
@ast
Defining daptomycin resistance ...... occus faecium and E. faecalis.
@en
Defining daptomycin resistance ...... occus faecium and E. faecalis.
@nl
type
label
Defining daptomycin resistance ...... occus faecium and E. faecalis.
@ast
Defining daptomycin resistance ...... occus faecium and E. faecalis.
@en
Defining daptomycin resistance ...... occus faecium and E. faecalis.
@nl
prefLabel
Defining daptomycin resistance ...... occus faecium and E. faecalis.
@ast
Defining daptomycin resistance ...... occus faecium and E. faecalis.
@en
Defining daptomycin resistance ...... occus faecium and E. faecalis.
@nl
P2093
P2860
P356
P1476
Defining daptomycin resistance ...... occus faecium and E. faecalis.
@en
P2093
B E Murray
C E Ireland
G Sakoulas
J Pogliano
P Nonejuie
P2860
P304
P356
10.1128/AAC.00098-14
P407
P50
P577
2014-06-23T00:00:00Z